These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18226173)

  • 41. The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model.
    Jeong SJ; Lim BJ; Park S; Choi D; Kim HW; Ku NS; Han SH; Kim CO; Choi JY; Song YG; Kim JM
    Inflamm Res; 2012 Nov; 61(11):1211-8. PubMed ID: 22777145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Potential of Receptor for Advanced Glycation End Products (RAGE) as a Therapeutic Target for Lung Associated Diseases.
    Khaket TP; Kang SC; Mukherjee TK
    Curr Drug Targets; 2019; 20(6):679-689. PubMed ID: 30457049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RAGE in tissue homeostasis, repair and regeneration.
    Sorci G; Riuzzi F; Giambanco I; Donato R
    Biochim Biophys Acta; 2013 Jan; 1833(1):101-9. PubMed ID: 23103427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis.
    Yan Z; Luo H; Xie B; Tian T; Li S; Chen Z; Liu J; Zhao X; Zhang L; Deng Y; Billiar TR; Jiang Y
    Nat Commun; 2021 Jan; 12(1):308. PubMed ID: 33436632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.
    Kislinger T; Tanji N; Wendt T; Qu W; Lu Y; Ferran LJ; Taguchi A; Olson K; Bucciarelli L; Goova M; Hofmann MA; Cataldegirmen G; D'Agati V; Pischetsrieder M; Stern DM; Schmidt AM
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):905-10. PubMed ID: 11397695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Receptor for Advanced Glycation End-Products (RAGE) Signaling on Intestinal Ischemic Damage in Mice.
    Makino Y; Munakata S; Ueyama T; Honjo K; Kawano S; Takahashi M; Kojima Y; Tomiki Y; Sakamoto K
    Eur Surg Res; 2019; 60(5-6):239-247. PubMed ID: 31914449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
    Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
    J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis.
    Ramasamy R; Yan SF; Herold K; Clynes R; Schmidt AM
    Ann N Y Acad Sci; 2008 Apr; 1126():7-13. PubMed ID: 18448789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor.
    LeBlanc PM; Doggett TA; Choi J; Hancock MA; Durocher Y; Frank F; Nagar B; Ferguson TA; Saleh M
    J Biol Chem; 2014 Mar; 289(11):7777-86. PubMed ID: 24474694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
    Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RAGE and cardiovascular disease.
    Park S; Yoon SJ; Tae HJ; Shim CY
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):486-97. PubMed ID: 21196183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ligands of RAGE-Proteins: Role in Intercellular Communication and Pathogenesis of Inflammation].
    Uspenskaya YA; Komleva YK; Pozhilenkova EA; Salmin VV; Lopatina OL; Fursov AA; Lavrentiev PV; Belova OA; Salmina AB
    Vestn Ross Akad Med Nauk; 2015; (6):694-703. PubMed ID: 27093797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.
    van Zoelen MA; Achouiti A; Schmidt AM; Yang H; Florquin S; Tracey KJ; van der Poll T
    Crit Care Med; 2010 Jun; 38(6):1414-22. PubMed ID: 20386310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging.
    Yan SF; Ramasamy R; Schmidt AM
    Biochem Pharmacol; 2010 May; 79(10):1379-86. PubMed ID: 20096667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products.
    Cecil DL; Johnson K; Rediske J; Lotz M; Schmidt AM; Terkeltaub R
    J Immunol; 2005 Dec; 175(12):8296-302. PubMed ID: 16339570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptor for advanced glycation endproducts and progressive kidney disease.
    Fukami K; Taguchi K; Yamagishi S; Okuda S
    Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):54-60. PubMed ID: 25470016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TREM-1, HMGB1 and RAGE in the Shoulder Tendon: Dual Mechanisms for Inflammation Based on the Coincidence of Glenohumeral Arthritis.
    Thankam FG; Dilisio MF; Dietz NE; Agrawal DK
    PLoS One; 2016; 11(10):e0165492. PubMed ID: 27792788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation.
    Moser B; Szabolcs MJ; Ankersmit HJ; Lu Y; Qu W; Weinberg A; Herold KC; Schmidt AM
    Am J Transplant; 2007 Feb; 7(2):293-302. PubMed ID: 17241110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
    Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
    Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.